DIA
IRWD icon

Denver Investment Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Denver Investment Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-25,427
Closed -$319K – 430
2017
Q4 		$319K Sell
25,427
-1,020
-4% -$13.3K 0.02% 370
2017
Q3 		$349K Buy
26,447
+167
+0.6% +$2.3K 0.02% 358
2017
Q2 		$416K Buy
+26,280
New +$382K 0.02% 347

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Denver Investment Advisors's IRWD Position: Q1 2018 in Review

Denver Investment Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2018, closing a stake of 25,427 shares — an estimated $319K sold.

Denver Investment Advisors first reported a position in IRWD in Q2 2017 and held it in 3 quarters. The position peaked at $416K in Q2 2017. 149 funds tracked by Wall St. Rank hold IRWD as of Q1 2018.

  • Denver Investment Advisors reported no remaining Ironwood Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Denver Investment Advisors sold 25,427 Ironwood Pharmaceuticals shares in Q1 2018, an estimated $319K.
  • Denver Investment Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2017 and held it in 3 quarters.
  • Denver Investment Advisors's Ironwood Pharmaceuticals position peaked at $416K in Q2 2017.
  • 149 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2018.

Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.